Closed To Recruitment

  1. ALOFT-PPF
    A Multiicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis (IM027-1015).
    Trial Age Group: Over 21 years Trial Disease Type: Progressive Pulmonary Fibrosis Trial Participant Type: Patient Trial Phase: Phase 3 Trial Location: NSW QLD VIC WA Trial Status: Closed to recruitment Recruiting Trial Type: Interventional
  2. ALOFT-IPF
    A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis (IM027-068).
    Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 3 Trial Location: NSW QLD VIC WA Trial Status: Closed to recruitment Trial Type: Interventional
  3. The TELO-SCOPE Study
    Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis.
    Trial Age Group: Over 18 years Under 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Interstitial Lung Disease (ILD) Progressive Fibrosing Interstitial Lung Diseases (PF-ILD) Pulmonary Fibrosis (PF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: NSW QLD VIC WA Trial Status: Closed to recruitment Trial Type: Interventional
  4. SHIELD
    The SHIELD Whole Lung Lavage Observational Cohort Study.
    Trial Age Group: Over 18 years Trial Disease Type: Silicosis Trial Participant Type: Patient Trial Phase: Not applicable Trial Location: NSW QLD VIC Trial Status: Closed to recruitment Trial Type: Observational
  5. SINFONIA
    A clinical trial examining the benefits of SingINg For breathing in COPD aNd ILD pAtients.
    Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient and Carer Trial Phase: Phase 3 Trial Location: NSW VIC Trial Status: Closed to recruitment Trial Type: Observational
  6. Novartis LTP001
    A participant and investigator-blinded, randomized, placebo-controlled, multicentre, platform study to investigate efficacy, safety, and tolerability of various single treatments in participants with idiopathic pulmonary fibrosis.
    Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Location: NSW QLD VIC WA Trial Status: Closed to recruitment Trial Type: Interventional